Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Explore how Insilico collaborates with Servier to advance AI-driven drug discovery in oncology for unmet medical needs.

InSilico Medicine Cayman TopCo, an artificial intelligence drug discovery startup, said on Monday that it has secured a ...

BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...

Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture. Ali Madani started thinking about how AI could be programmed for biology in 2020, ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Multi-year partnership with France's Servier will use Insilico's AI platform to explore novel cancer drugs Newly Hong ...

UB researcher Murali Ramanathan has used artificial intelligence (AI) since its nascent days while exploring possible treatments for multiple sclerosis (MS) and Alzheimer’s disease. Today, Ramanathan, ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...